SCN1A mutations, often associated with Dravet syndrome, disrupt sodium channel function and lead to prolonged seizures and autonomic instability, which increase the risk of bradycardia and other arrhythmias [271]. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.